1. Implementation of a pharmacogenomics consult service to support the INGENIOUS trial
- Author
-
Michael T. Eadon, David A. Flockhart, Brian S. Decker, Rebecca C. Pierson, Brandon T. Gufford, Janet S. Carpenter, N Dave, John T. Callaghan, J. D. Robarge, Mustafa Hyder, Rolf P. Kreutz, Victoria M. Pratt, Marc B. Rosenman, Raj Vuppalanchi, Paul R. Dexter, C.A. McDonald, Ann M. Holmes, Kenneth D. Levy, David M. Haas, Avinash S. Patil, Eric A. Benson, Zeruesenay Desta, and Todd C. Skaar
- Subjects
0301 basic medicine ,Pharmacology ,Academic Medical Centers ,Medically Uninsured ,Safety-net Provider ,Service (systems architecture) ,business.industry ,Pharmacogenomic Testing ,Credentialing ,Vulnerable Populations ,030226 pharmacology & pharmacy ,Article ,03 medical and health sciences ,030104 developmental biology ,0302 clinical medicine ,Nursing ,Pharmacogenetics ,Pharmacogenomics ,Humans ,Medicine ,Pharmacology (medical) ,business ,Poverty ,Safety-net Providers ,Adjudication - Abstract
Hospital systems increasingly utilize pharmacogenomic testing to inform clinical prescribing. Successful implementation efforts have been modeled at many academic centers. In contrast, this report provides insights into the formation of a pharmacogenomics consultation service at a safety-net hospital, which predominantly serves low-income, uninsured, and vulnerable populations. The report describes the INdiana GENomics Implementation: an Opportunity for the UnderServed (INGENIOUS) trial and addresses concerns of adjudication, credentialing, and funding.
- Published
- 2016
- Full Text
- View/download PDF